Showing results (131-140 of 463) with videos related to
Sort By:
Pageof 47
The European Journal of Neuroscience|May 28, 2011
Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned ratsMaria Papathanou, Sarah Rose, Andrew McCreary, et al.Journal of Parkinson'S Disease|December 27, 2021
Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and FutureYu-Yan Tan, Peter Jenner, Sheng-Di ChenThe European Journal of Neuroscience|March 16, 2004
Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleusJosé L Lanciego, Nancy Gonzalo, Maria Castle, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2018
Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicineMargherita Fabbri, Joaquim J Ferreira, Andrew Lees, et al.Future Microbiology|October 21, 2020
The impact of intestinal microbiota on weight loss in Parkinson's disease patients: a pilot studyFederica Del Chierico, Paola Grassini, Andrea Quagliariello, et al.Expert Review of Neurotherapeutics|June 6, 2017
Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPAAndrew J Lees, Joaquim Ferreira, Olivier Rascol, et al.Frontiers in Neuroanatomy|June 15, 2017
Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated MonkeysChristian Pifl, Harald Reither, Natalia Lopez-Gonzalez Del Rey, et al.Clinical Neuropharmacology|July 21, 2006
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatmentGiovanni Palleschi, Antonio Luigi Pastore, Fabrizio Stocchi, et al.Expert Review of Neurotherapeutics|February 2, 2023
Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approachAndrew Lees, Eduardo Tolosa, Fabrizio Stocchi, et al.Journal of Neurochemistry|July 23, 2003
Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteinsDong-Hoon Hyun, MoonHee Lee, Barry Halliwell, et al.Pageof 47